Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Eur J Intern Med ; 123: 114-119, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38123419

RESUMEN

OBJECTIVE: Due to increased use of computed tomography (CT), prevalence of thyroid and adrenal incidentalomas is rising. Yet, previous studies on the outcomes of diagnostic work-up of incidentalomas are subjected to inclusion bias. Therefore, we aimed to investigate prevalence and outcomes of diagnostic work-up of thyroid and adrenal incidentalomas detected on chest CT in a less selected population of COVID-19 suspected patients. DESIGN: A retrospective, observational cohort study. METHODS: We included all COVID-19 suspected patients who underwent chest CT between March 2020 and March 2021. Radiology reports and medical records were reviewed for the presence and subsequent diagnostic work-up of thyroid and adrenal incidentalomas. RESULTS: A total of 1,992 consecutive COVID-19 patients were included (59.4% male, median age 71 years [IQR: 71-80]). Thyroid and adrenal incidentalomas were identified in 95 (4.8%) and 133 (6.7%) patients, respectively. Higher prevalence was observed with increasing age, among female patients and in patients with malignancy. Forty-four incidentalomas were further analyzed, but no malignancies were found. Only three lesions were hormonally active (1 thyrotoxicosis and 2 mild autonomous cortisol secretion). Diagnostic work-up did not lead to any change in clinical management in 97.7% of the analyzed patients. CONCLUSION: Prevalence rates of thyroid and adrenal incidentalomas on chest CT in a less selected COVID-19 cohort were 4.8% and 6.7%, respectively. Yet, as all incidentalomas turned out to be benign and only three lesions were (mildly) hormonally active, this raises the question whether intensive diagnostic work-up of incidentalomas is necessary in all patients.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales , COVID-19 , Hallazgos Incidentales , Neoplasias de la Tiroides , Tomografía Computarizada por Rayos X , Humanos , Masculino , Femenino , Anciano , COVID-19/epidemiología , COVID-19/diagnóstico por imagen , COVID-19/diagnóstico , Estudios Retrospectivos , Neoplasias de las Glándulas Suprarrenales/diagnóstico por imagen , Neoplasias de las Glándulas Suprarrenales/epidemiología , Prevalencia , Anciano de 80 o más Años , Neoplasias de la Tiroides/epidemiología , Neoplasias de la Tiroides/diagnóstico por imagen , Neoplasias de la Tiroides/diagnóstico , SARS-CoV-2 , Persona de Mediana Edad
2.
Ned Tijdschr Geneeskd ; 155(50): A3702, 2011.
Artículo en Holandés | MEDLINE | ID: mdl-22186362

RESUMEN

Three-dimensional (3-D) ultrasound is a technique, in which almost the entire breast is automatically scanned. Data sets can be stored and reviewed at a later date. This almost completely eliminates the subjective character of conventional ultrasound, enabling a more reliable review and follow-up. 3-D ultrasound can be implemented in daily radiological practice and could possibly be used in population screening programmes for breast cancer.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Ultrasonografía Mamaria/métodos , Neoplasias de la Mama/diagnóstico , Femenino , Humanos , Imagenología Tridimensional
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA